Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation

New therapy with unique bacterial strain B. bifidum HI-MIMBb75 promises help for approximately 80 million Europeans suffering from irritable bowel syndrome1 World's largest clinical OTC irritable bowel syndrome trial investigating the efficacy of this particular strain published in the renowned medical journal The Lancet Gastroenterology & Hepatology2 Results show significant efficacy for all predominant irritable bowel syndrome symptoms and all subtypes while simultaneously improving patients’ quality of life2 (Gräfelfing/Munich, Germany) The world's largest OTC irritable bowel syndrome (IBS) trial comes up with remarkable results, which were recently published in the renowned medical journal The Lancet Gastroenterology & Hepatology. For the first time, leading German scientists around Prof. Dr. Peter Layer (Israelitic Hospital Hamburg) were able to prove the significant efficacy of a heat-inactivated bacterial strain on patients with IBS. Trial results show that B. bifidum HI-MIMBb75

Frontiers The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome - Camilleri - 2012 - Clinical Pharmacology & Therapeutics - Wiley Online Library

PDF) Herbal Therapy is Effective for Rifaximin Non-Responders with Small Intestinal Bacterial Overgrowth (SIBO) and the Irritable Bowel Syndrome (IBS)

Frontiers Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis

Irritable Bowel Syndrome

A role for the gut microbiota in IBS Nature Reviews Gastroenterology & Hepatology

Management of the multiple symptoms of irritable bowel syndrome - The Lancet Gastroenterology & Hepatology

A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers

Pharmaceuticals, Free Full-Text

Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation - Food & Function (RSC Publishing) DOI:10.1039/D0FO02855J

Gastrointestinal Disorders, Free Full-Text

Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review, Gut Microbiome